Title: Inhibition of hedgehog signalling preventsexperimental fibrosis and induces regression ofestablished fibrosis
Abstract: Objectives Tissue fi brosis is a leading cause of death
in patients with systemic sclerosis (SSc). Effective
antifi brotic treatments are not available. Here, the
authors investigated inhibition of hedgehog signalling
by targeting Smoothened (Smo) as a novel antifi brotic
approach.
Methods The activation status of the hedgehog
pathway was assessed by immunohistochemistry for Gli
transcription factors and by quantifi cation of hedgehog
target genes. Hedgehog signalling was inhibited by the
selective inhibitor LDE223 and by small interfering RNA
against Smo in the models of bleomycin-induced dermal
fi brosis and in tight-skin-1 mice.
Results Hedgehog signalling is activated in SSc and in
murine models of SSc. Inhibition of Smo either by LDE223
or by small interfering RNA prevented dermal thickening,
myofi broblast differentiation and accumulation of collagen
upon challenge with bleomycin. Targeting Smo also
exerted potent antifi brotic effects in tight-skin-1 mice and
did prevent progression of fi brosis and induced regression
of pre-established fi brosis.
Conclusions Inhibition of hedgehog signalling exerted
potent antifi brotic effects in preclinical models of SSc in
both preventive and therapeutic settings. These fi ndings
might have direct translational implications because
inhibitors of Smo are already available and yielded
promising results in initial clinical trials.
Publication Year: 2012
Publication Date: 2012-05-08
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot